SPAR PHARMA LLP
Overview
SPAR PHARMA LLP is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering (±)-4-FLUORO-A.-(2-METHYL-1-OXOPROPYL)- Y-OXO-N, ß - DIPHENYL BENZENE BUTANEAMIDE (DKT).
Core services & business areas
API / Drug Master Files
SPAR PHARMA LLP holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- (±)-4-FLUORO-A.-(2-METHYL-1-OXOPROPYL)- Y-OXO-N, ß - DIPHENYL BENZENE BUTANEAMIDE (DKT)Active2024-07-17
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SPAR PHARMA LLP in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SPAR PHARMA LLP? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.